Gossamer Bio Faces Delisting Concerns
Ticker: GOSS · Form: 8-K · Filed: Apr 9, 2026 · CIK: 0001728117
| Field | Detail |
|---|---|
| Company | Gossamer Bio, Inc. (GOSS) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, regulatory-issue
Related Tickers: GOSS
TL;DR
GOSS might get delisted - big trouble ahead.
AI Summary
Gossamer Bio, Inc. filed an 8-K on April 9, 2026, to report a notice of delisting or failure to satisfy a continued listing rule or standard, as of April 8, 2026. This indicates potential issues with the company's compliance with stock exchange listing requirements.
Why It Matters
This filing signals potential financial distress or non-compliance, which could lead to the stock being removed from its exchange, impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- Gossamer Bio, Inc. (company) — Filer of the 8-K report
- 0001728117 (company) — CIK number for Gossamer Bio, Inc.
- 2026-04-09 (date) — Filing date of the 8-K
- 2026-04-08 (date) — Period of report for the delisting notice
FAQ
What specific listing rule or standard has Gossamer Bio, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Gossamer Bio, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the effective date of the delisting notice?
The period of report for the delisting notice is April 8, 2026.
What actions, if any, does Gossamer Bio, Inc. plan to take to address the delisting concerns?
The provided filing details do not include information on any specific actions Gossamer Bio, Inc. plans to take to address the delisting concerns.
Which stock exchange is Gossamer Bio, Inc. listed on?
The filing does not explicitly state the stock exchange, but the context of a 'continued listing rule or standard' implies it is listed on a major exchange.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 9, 2026, at 16:01:13.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2026 regarding Gossamer Bio, Inc. (GOSS).